BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31396074)

  • 1. Neuropsychiatric Symptoms as Predictors of Clinical Course in Neurodegeneration. A Longitudinal Study.
    Santacruz Escudero JM; Beltrán J; Palacios Á; Chimbí CM; Matallana D; Reyes P; Perez-Sola V; Santamaría-García H
    Front Aging Neurosci; 2019; 11():176. PubMed ID: 31396074
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific Neuropsychiatric Symptoms Are Associated with Faster Progression in Alzheimer's Disease: Results of the Prospective Dementia Registry (PRODEM-Austria).
    Defrancesco M; Marksteiner J; Kemmler G; Dal-Bianco P; Ransmayr G; Benke T; Mosbacher J; Höller Y; Schmidt R
    J Alzheimers Dis; 2020; 73(1):125-133. PubMed ID: 31744004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of behavioral and psychological symptoms on caregiver burden in frontotemporal dementia, Lewy body dementia, and Alzheimer's disease: clinical experience in China.
    Liu S; Jin Y; Shi Z; Huo YR; Guan Y; Liu M; Liu S; Ji Y
    Aging Ment Health; 2017 Jun; 21(6):651-657. PubMed ID: 26882509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating traits and states identifies the importance of chronic neuropsychiatric symptoms for cognitive prognosis in mild dementia.
    Giil LM; Aarsland D; Vik-Mo AO
    Alzheimers Dement (Amst); 2021; 13(1):e12152. PubMed ID: 33665342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight Change and Neuropsychiatric Symptoms in Alzheimer's Disease and Frontotemporal Dementia: Associations with Cognitive Decline.
    Morrow CB; Leoutsakos J; Yan H; Onyike C; Kamath V
    J Alzheimers Dis Rep; 2023; 7(1):767-774. PubMed ID: 37662607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach.
    D'Onofrio G; Panza F; Sancarlo D; Paris FF; Cascavilla L; Mangiacotti A; Lauriola M; Paroni GH; Seripa D; Greco A
    J Alzheimers Dis; 2016; 51(2):427-37. PubMed ID: 26890768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms.
    Liguori C; Mercuri NB; Nuccetelli M; Izzi F; Bernardini S; Placidi F
    J Alzheimers Dis; 2018; 66(3):993-999. PubMed ID: 30372684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case series of mild behavioral impairment: toward an understanding of the early stages of neurodegenerative diseases affecting behavior and cognition.
    Cieslak A; Smith EE; Lysack J; Ismail Z
    Int Psychogeriatr; 2018 Feb; 30(2):273-280. PubMed ID: 29017626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apathy in frontotemporal dementia and Alzheimer's disease: are there distinct profiles?].
    Derouesné C; Lacomblez L; Fiori N; Gély-Nargeot MC; Bungener C
    Geriatr Psychol Neuropsychiatr Vieil; 2012 Mar; 10(1):107-15. PubMed ID: 22414405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
    Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
    J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.
    Hallikainen I; Hongisto K; Välimäki T; Hänninen T; Martikainen J; Koivisto AM
    J Alzheimers Dis; 2018; 61(4):1367-1376. PubMed ID: 29376861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.
    Rosenberg PB; Lanctôt KL; Herrmann N; Mintzer JE; Porsteinsson AP; Sun X; Raman R
    J Alzheimers Dis; 2016 Aug; 54(1):373-81. PubMed ID: 27567808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific neuropsychiatric symptoms are associated with functional decline trajectories in Alzheimer's disease and Lewy body dementia: a five-year follow-up study.
    Borda MG; Brønnick KK; Garcia-Cifuentes E; Jaramillo-Jimenez A; Reyes-Ortiz C; Patricio-Baldera J; Soennesyn H; Pérez-Zepeda MU; Vik-Mo AO; Aarsland D
    Front Med (Lausanne); 2023; 10():1267060. PubMed ID: 37915329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study.
    Vik-Mo AO; Giil LM; Ballard C; Aarsland D
    Int J Geriatr Psychiatry; 2018 Oct; 33(10):1361-1369. PubMed ID: 29979473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Neuropsychiatric Improvement and Neurocognitive Change in Alzheimer's Disease: Analysis of the CATIE-AD Study.
    Nagata T; Shinagawa S; Nakajima S; Mimura M; Shigeta M
    J Alzheimers Dis; 2018; 66(1):139-148. PubMed ID: 30248052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease.
    Karttunen K; Karppi P; Hiltunen A; Vanhanen M; Välimäki T; Martikainen J; Valtonen H; Sivenius J; Soininen H; Hartikainen S; Suhonen J; Pirttilä T;
    Int J Geriatr Psychiatry; 2011 May; 26(5):473-82. PubMed ID: 21445998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease and frontal variant of frontotemporal dementia-- a very brief battery for cognitive and behavioural distinction.
    Perri R; Koch G; Carlesimo GA; Serra L; Fadda L; Pasqualetti P; Pettenati C; Caltagirone C
    J Neurol; 2005 Oct; 252(10):1238-44. PubMed ID: 15906058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.